Disease Susceptibility: Clinical Trials

5 trials for Disease Susceptibility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Not yet recruiting 1, Recruiting 1, Terminated 1

Follow Disease Susceptibility: new trials by email Literature Review of Disease Susceptibility trials Research Report on Disease Susceptibility

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans
Exendin 9-39, Saline - Genetic Predisposition, Type2diabetes
Phase 2Not yet recruitingMayo Clinic802026-10-012026-01-30
Microbiome and Association With Implant Infections
Cephalexin - Breast Cancer, Breast Cancer Female
Phase 2RecruitingUniversity of California, San Francisco2002021-09-282026-03-18
Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
Lisinopril, Placebo Oral Tablet - HIV/AIDS, Albuminuria
Phase 2TerminatedVanderbilt University Medical Center662021-04-012025-06-26
Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus
Daptomycin, PMX-30063-investigational drug - Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA), (Susceptible or Methicillin Resistant)
Phase 2CompletedPolyMedix, Inc.2152010-10-012012-05-17
Clopidogrel Pharmacogenomics Project
clopidogrel 75 mg, Clopidogrel 150 mg - Disease Susceptibility
Phase 2CompletedUniversity of North Carolina, Chapel Hill502010-03-012017-12-12

Narrower conditions

Genetic Predisposition to Disease (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Albuminuria (1)  ·  Breast Neoplasms (1)  ·  Kidney Diseases (1)  ·  Staphylococcal Infections (1)

Broader conditions

Disease Attributes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Infections (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Blood-Borne Infections (1)  ·  Breast Diseases (1)  ·  Communicable Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  HIV Infections (1)

Interventions

Cephalexin (1)  ·  Clopidogrel (1)  ·  Daptomycin (1)  ·  Lisinopril (1)  ·  Sodium Chloride (1)  ·  exendin (9-39) (1)

Sponsors

Mayo Clinic (1)  ·  PolyMedix, Inc. (1)  ·  University of California, San Francisco (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Canada (1)  ·  Nigeria (1)  ·  Russia (1)  ·  Ukraine (1)

Top investigators

Adrian Vella, MD (1)  ·  C. William Wester, MD, MPH (1)  ·  Joseph Rossi, MD (1)  ·  Merisa Piper, MD (1)  ·  Muktar H. Aliyu, MD, DrPH (1)

NIH funding

U01DK112271 (1)